These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4657205)

  • 21. Apoptosis and immune responses to self.
    Navratil JS; Sabatine JM; Ahearn JM
    Rheum Dis Clin North Am; 2004 Feb; 30(1):193-212. PubMed ID: 15061575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune uveitis and antigenic mimicry of environmental antigens.
    Wildner G; Diedrichs-Möhring M
    Autoimmun Rev; 2004 Jul; 3(5):383-7. PubMed ID: 15288005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The induction of tolerance and suppression in autoimmune MRL mice using hapten-modified self.
    Santoro TJ; Scott DW; Pisetsky DS
    J Immunol; 1981 Aug; 127(2):690-3. PubMed ID: 7252156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posttranslational modifications of self-antigens.
    Doyle HA; Mamula MJ
    Ann N Y Acad Sci; 2005 Jun; 1050():1-9. PubMed ID: 16014515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis.
    Gregerson DS; Torseth JW; McPherson SW; Roberts JP; Shinohara T; Zack DJ
    J Immunol; 1999 Jul; 163(2):1073-80. PubMed ID: 10395707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens.
    Pontes-de-Carvalho L; Santana CC; Soares MB; Oliveira GG; Cunha-Neto E; Ribeiro-dos-Santos R
    J Autoimmun; 2002 Mar; 18(2):131-8. PubMed ID: 11908945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
    Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial parasitism cross-reactive with host antigen: implications concerning loss of "self" tolerance and development of autoimmune disease.
    Paterson PY
    Recomb DNA Tech Bull; 1981 Sep; 4(3):98-107. PubMed ID: 6169118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autoimmunity].
    Müller C
    Schweiz Med Wochenschr; 1997 Mar; 127(9):333-40. PubMed ID: 9132931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of autoantibody production].
    Misaki Y
    Rinsho Byori; 2001 Jun; 49(6):566-70. PubMed ID: 11452542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autoaggression and self tolerance. The pathogenesis of autoimmune diseases].
    Begemann M
    Med Klin; 1981 Feb; 76(5):118-27. PubMed ID: 6452569
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral toleragens in rheumatoid arthritis.
    Choy EH
    Curr Opin Investig Drugs; 2000 Sep; 1(1):58-62. PubMed ID: 11249596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
    Miller SD; Turley DM; Podojil JR
    Nat Rev Immunol; 2007 Sep; 7(9):665-77. PubMed ID: 17690713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pyruvate dehydrogenase complex as a target autoantigen in primary biliary cirrhosis.
    Nishio A; Coppel R; Ishibashi H; Gershwin ME
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):535-47. PubMed ID: 10976013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral tolerance. Eating your way towards immunosuppression.
    MacDonald TT
    Curr Biol; 1994 Feb; 4(2):178-81. PubMed ID: 7953527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
    Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH
    J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulation of experimental autoimmune diseases via oral tolerance.
    Krause I; Blank M; Shoenfeld Y
    Crit Rev Immunol; 2000; 20(1):1-16. PubMed ID: 10770268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral tolerance in the control of experimental models of autoimmune disease.
    Staines NA; Harper N
    Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autoaggression].
    Vorlaender KO
    Hippokrates; 1972 Sep; 43(3):267-80. PubMed ID: 4641349
    [No Abstract]   [Full Text] [Related]  

  • 40. Opinion on Immune Tolerance Therapeutic Development.
    Radi ZA; Wynn TA
    Toxicol Pathol; 2020 Aug; 48(6):712-717. PubMed ID: 32815472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.